Effect of desvenlafaxine on mood and climacteric symptoms in menopausal women with moderate to severe vasomotor symptoms

References

• National Institutes of Health. National Institutes of Health State-of-the-Science Conference statement: management of menopause-related symptoms. Ann Intern Med 2005;142:1003–13
   PubMedGoogle Scholar
• Freeman EW, Sherif K. Prevalence of hot flushes and night sweats around the world: a systematic review. Climacteric 2007;10:197–214
   PubMed Web of Science ®Google Scholar
• Utian WH. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review. Health Qual Life Outcomes 2005;3:47
   PubMedGoogle Scholar
• Kravitz HM, Ganz PA, Bromberger J, . Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause 2003;10:19–28
   PubMed Web of Science ®Google Scholar
• Ohayon MM. Severe hot flashes are associated with chronic insomnia. Arch Intern Med 2006;166:1262–8
   PubMed Web of Science ®Google Scholar
• Freedman RR, Roehrs TA. Effects of REM sleep and ambient temperature on hot flash-induced sleep disturbance. Menopause 2006;13:576–83
   PubMed Web of Science ®Google Scholar
• Bromberger JT, Assmann SF, Avis NE, . Persistent mood symptoms in a multiethnic community cohort of pre- and perimenopausal women. Am J Epidemiol 2003;158:347–56
   PubMed Web of Science ®Google Scholar
• Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry 2006;63:385–90
   PubMed Web of Science ®Google Scholar
• Joffe H, Hall JE, Soares CN, . Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care. Menopause 2002;9:392–8
   PubMed Web of Science ®Google Scholar
• Bosworth HB, Bastian LA, Kuchibhatla MN, . Depressive symptoms, menopausal status, and climacteric symptoms in women at midlife. Psychosom Med 2001;63:603–8
   PubMed Web of Science ®Google Scholar
• Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG. A prospective population-based study of menopausal symptoms. Obstet Gynecol 2000;96:351–8
   PubMed Web of Science ®Google Scholar
• Avis NE, Brambilla D, McKinlay SM, Vass K. A longitudinal analysis of the association between menopause and depression. Results from the Massachusetts Women’s Health Study. Ann Epidemiol 1994;4:214–20
   PubMedGoogle Scholar
• MacLennan AH, Broadbent JL, Lester S, Moore V. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev 2004;CD002978
   Google Scholar
• Schmidt PJ, Nieman L, Danaceau MA, . Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol 2000;183:414–20
   PubMed Web of Science ®Google Scholar
• Soares CN, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 2001;58:529–34
   PubMed Web of Science ®Google Scholar
• Morrison MF, Kallan MJ, Ten HT, . Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial. Biol Psychiatry 2004;55:406–12
   PubMed Web of Science ®Google Scholar
• Zweifel JE, O’Brien WH. A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology 1997;22:189–212
   PubMed Web of Science ®Google Scholar
• McEwen B. Estrogen actions throughout the brain. Recent Prog Horm Res 2002;57:357–84
   PubMedGoogle Scholar
• Delgado PL. Common pathways of depression and pain. J Clin Psychiatry 2004;65:16–19
   PubMed Web of Science ®Google Scholar
• Soares CN, Arsenio H, Joffe H, . Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life. Menopause 2006;13:780–6
   PubMed Web of Science ®Google Scholar
• Loprinzi CL, Flynn PJ, Carpenter LA, . Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine. J Palliat Med 2005;8:924–30
   PubMedGoogle Scholar
• Barton DL, Loprinzi CL, Novotny P, . Pilot evaluation of citalopram for the relief of hot flashes. J Support Oncol 2003; 1:47–51
   Google Scholar
• Stearns V, Isaacs C, Rowland J, . A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors. Ann Oncol 2000;11:17–22
   PubMed Web of Science ®Google Scholar
• Weitzner MA, Moncello J, Jacobsen PB, Minton S. A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer. J Pain Symptom Manage 2002;23:337–45
   PubMed Web of Science ®Google Scholar
• Biglia N, Torta R, Roagna R, . Evaluation of low-dose venlafaxine hydrochloride for the therapy of hot flushes in breast cancer survivors. Maturitas 2005;52:78–85
   PubMed Web of Science ®Google Scholar
• Pristiq [package insert]. Philadelphia, PA: Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer, 2011.
   Google Scholar
• Archer DF, Seidman L, Constantine GD, . A double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopause. Am J Obstet Gynecol 2009;200:172.e1–10
   Web of Science ®Google Scholar
• Speroff L, Gass M, Constantine G, Olivier S, for the Study 315 investigators. Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial. Obstet Gynecol 2008;111:77–87
   PubMed Web of Science ®Google Scholar
• Archer DF, Dupont CM, Constantine GD, . Desvenlafaxine for the treatment of vasomotor symptoms associated with menopause: a double-blind, randomized, placebo-controlled trial of efficacy and safety. Am J Obstet Gynecol 2009;200:238.e1–10
   Web of Science ®Google Scholar
• Miller KJ, Conney JC, Rasgon NL, Fairbanks LA, Small GW. Mood symptoms and cognitive performance in women estrogen users and nonusers and men. J Am Geriatr Soc 2002;50:1826–30
   PubMed Web of Science ®Google Scholar
• Cummings JA, Brizendine L. Comparison of physical and emotional side effects of progesterone or medroxyprogesterone in early postmenopausal women. Menopause 2002;9:253–63
   PubMed Web of Science ®Google Scholar
• Boyle GJ, Murrihy R. A preliminary study of hormone replacement therapy and psychological mood states in perimenopausal women. Psychol Rep 2001;88:160–70
   PubMed Web of Science ®Google Scholar
• Slaven L, Lee C. Mood and symptom reporting among middle-aged women: the relationship between menopausal status, hormone replacement therapy, and exercise participation. Health Psychol 1997;16:203–8
   PubMed Web of Science ®Google Scholar
• Greene JG. Constructing a standard climacteric scale. Maturitas 1998;29:25–31
   PubMed Web of Science ®Google Scholar
• Hill CD, Fehnel SE, Bobula JD, Yu H, McLeod LD. Development and preliminary validation of the Menopause Symptoms Treatment Satisfaction Questionnaire (MS-TSQ). Menopause 2007;14:1047–55
   PubMed Web of Science ®Google Scholar
• DeLoach LJ, Higgins MS, Caplan AB, Stiff JL. The visual analog scale in the immediate postoperative period: intrasubject variability and correlation with a numeric scale. Anesth Analg 1998;86:102–6
   PubMed Web of Science ®Google Scholar
• Avis NE, Crawford S, Stellato R, Longcope C. Longitudinal study of hormone levels and depression among women transitioning through menopause. Climacteric 2001;4:243–9
   PubMedGoogle Scholar
• Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 2006;63:375–82
   PubMed Web of Science ®Google Scholar
• Liebowitz MR, Manley AL, Padmanabhan SK, . Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorder. Curr Med Res Opin 2008;24:1877–90
   PubMed Web of Science ®Google Scholar
• Magliano M. Menopausal arthralgia: fact or fiction. Maturitas 2010;67:29–33
   PubMed Web of Science ®Google Scholar
• Freeman MP, Hill R, Brumbach BH. Escitalopram for perimenopausal depression: an open-label pilot study. J Womens Health (Larchmt) 2006;15:857–61
   PubMed Web of Science ®Google Scholar
• Ladd CO, Newport DJ, Ragan KA, Loughhead A, Stowe ZN. Venlafaxine in the treatment of depressive and vasomotor symptoms in women with perimenopausal depression. Depress Anxiety 2005;22:94–7
   PubMed Web of Science ®Google Scholar
• Cohen LS, Soares CN, Poitras JR, . Short-term use of estradiol for depression in perimenopausal and postmenopausal women: a preliminary report. Am J Psychiatry 2003;160:1519–22
   PubMed Web of Science ®Google Scholar
• Soares CN, Prouty J, Born L, Steiner M. Treatment of menopause-related mood disturbances. CNS Spectr 2005;10:489–97
   PubMed Web of Science ®Google Scholar
• Baber RJ, Templeman C, Morton T, Kelly GE, West L. Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric 1999;2:85–92
   PubMedGoogle Scholar
• Knight DC, Howes JB, Eden JA. The effect of Promensil, an isoflavone extract, on menopausal symptoms. Climacteric 1999; 2:79–84
   PubMedGoogle Scholar
• van de Weijer PHM, Barentsen R. Isoflavones from red clover (Promensil®) significantly reduce menopausal hot flush symptoms compared with placebo. Maturitas 2002;42:187–93
   PubMed Web of Science ®Google Scholar
• Tice JA, Ettinger B, Ensrud K, . Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial. JAMA 2003;290:207–14
   Web of Science ®Google Scholar
• Secreto G, Chiechi LM, Amadori A, . Soy isoflavones and melatonin for the relief of climacteric symptoms: a multicenter, double-blind, randomized study. Maturitas 2004;47:11–20
   PubMed Web of Science ®Google Scholar
• Duffy R, Wiseman H, File SE. Improved cognitive function in postmenopausal women after 12 weeks of consumption of a soya extract containing isoflavones. Pharmacol Biochem Behav 2003; 75:721–9
   PubMed Web of Science ®Google Scholar
• Verhoeven MO, van der Mooren MJ, van de Weijer PHM, . Effect of a combination of isoflavones and Actaea racemosa Linnaeus on climacteric symptoms in healthy symptomatic perimenopausal women: a 12-week randomized, placebo-controlled, double-blind study. Menopause 2005;12:412–20
   PubMed Web of Science ®Google Scholar
• Geller SE, Shulman LP, van Breemen RB, . Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial. Menopause 2009;16:1156–66
   Web of Science ®Google Scholar
• Lontos S, Jones RM, Angus PW, Gow PJ. Acute liver failure associated with the use of herbal preparations containing black cohosh. Med J Aust 2003;179:390–1
   PubMed Web of Science ®Google Scholar
• Lynch CR, Folkers ME, Hutson WR. Fulminant hepatic failure associated with the use of black cohosh: a case report. Liver Transpl 2006;12:989–92
   PubMed Web of Science ®Google Scholar
• Cagnacci A, Arangino S, Renzi A, . Kava-Kava administration reduces anxiety in perimenopausal women. Maturitas 2003;44:103–9
   PubMed Web of Science ®Google Scholar
• Biglia N, Sgandurra P, Peano E, . Non-hormonal treatment of hot flushes in breast cancer survivors: gabapentin vs. vitamin E. Climacteric 2009;12:310–18
   PubMed Web of Science ®Google Scholar
• Reddy SY, Warner H, Guttuso T Jr, . Gabapentin, estrogen, and placebo for treating hot flushes: a randomized controlled trial. Obstet Gynecol 2006;108:41–8
   PubMed Web of Science ®Google Scholar
• Guttuso T, Kurlan R, McDermott MP, Kieburtz K. Gabapentin’s effects on hot flashes in postmenopausal women: a randomized controlled trial. Obstet Gynecol 2003;101:337–45
   PubMed Web of Science ®Google Scholar
• Salmi T, Punnonen R. Clonidine in the treatment of menopausal symptoms. Int J Gynaecol Obstet 1979;16:422–6
   PubMedGoogle Scholar
• Wren BG, Brown LB. A double-blind trial with clonidine and a placebo to treat hot flushes. Med J Aust 1986;144:369–70
   PubMed Web of Science ®Google Scholar
• Pandya KJ, Raubertas RF, Flynn PJ, . Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study. Ann Intern Med 2000;132:788–93
   PubMed Web of Science ®Google Scholar
• Kornstein SG, Jiang Q, Reddy S, Musgnung JJ, Guico-Pabia CJ. Short-term efficacy and safety of desvenlafaxine in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder. J Clin Psychiatry 2010;71:1088–96
   PubMed Web of Science ®Google Scholar